Posts Tagged ‘FDA’
Joe Elia • May 19th, 2011
A paper from Denmark looks at five newer-generation antiepileptics and finds no strong birth-defects signal associated with their use in the first trimester. However, as the senior author points out in a statement to Clinical Conversations, one of the drugs — topiramate — has only recently been cited by the FDA as carrying a [...]
Joe Elia • September 26th, 2010
Prof. Martin Dennis chats with us about his latest trial, comparing the utility of thigh- versus below-knee-length stockings for patients immobilized after stroke. The latest results show the superiority of thigh-length stockings, but at the further risk of skin breaks in these vulnerable patients. Taken together with the results of his earlier work, at [...]
Joe Elia • August 20th, 2010
Our interview this week is with a research nutritionist whose BMJ meta-analysis found a 14% reduction in risk for type 2 diabetes among those with the highest intake (versus those with the lowest) of leafy green vegetables. It’s a meta-analysis, and not a randomized controlled trial, and it’s interesting. Listen in. We’re off next [...]
Joe Elia • July 30th, 2010
What becomes of children who survive cancer treatment and enter their reproductive years? Would their attempts to have children end in a higher-than-normal rate of stillbirths and miscarriages? Apparently not. It turns out the major concern is with women who’ve undergone pelvic irradiation before menarche. That treatment seems to hobble uterine development, but not [...]
Joe Elia • May 16th, 2010
Dr. Robert Centor of the University of Alabama at Birmingham believes that the paradigm for treating pharyngitis in adolescents and young adults must change. Listen to our conversation and hear why. Here are this week’s links: Interview-related links: Commentary Urges ‘Expanding the Diagnostic Paradigm of Pharyngitis’ in Young People Robert Centor’s blog — “Medrants” [...]
Joe Elia • February 27th, 2010
A conversation with the authors of an Archives of Internal Medicine study that examines the best tactics for saying “No” to inappropriate requests. Contact me at 1-617-440-4374 or at jelia@jwatch.org. Interview-related links: Archives of Internal Medicine abstract Atul Gawande’s New Yorker article News-related links: The rosiglitazone (Avandia) controversy Advisory on thiazolidinediones Physicians’ work hours 13-valent [...]
(5 votes, average: 3.60 out of 5)
